AMENDMENT NO. 1Offer Letter • May 7th, 2018 • Menlo Therapeutics Inc. • Pharmaceutical preparations
Contract Type FiledMay 7th, 2018 Company IndustryThis Amendment No. 1 to Offer Letter (the “Amendment”) is entered into as of May 3, 2018, by and between Menlo Therapeutics Inc., a Delaware corporation (the “Company”) and Paul Kwon (“Executive”).
AMENDMENT NO. 1Offer Letter • May 7th, 2018 • Menlo Therapeutics Inc. • Pharmaceutical preparations
Contract Type FiledMay 7th, 2018 Company IndustryThis Amendment No. 1 to Offer Letter (the “Amendment”) is entered into as of May 3, 2018, by and between Menlo Therapeutics Inc., a Delaware corporation (the “Company”) and Kristine Ball (“Executive”).